VHL and nonpapillary renal cell carcinoma: Given that a significant fraction of ccRCCs display intrinsic resistance to HIF2A inhibition and anti-angiogenic agents9,20, a better understanding of the molecular dependencies of VHL mutant ccRCC is needed.